clinical trials tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo- controlled, phase 3 trial Weight-loss drug tirzepatide may lower

Bei einer Kombinationstherapie mit Insulin, kann Tirzepatid dazu beitragen, dass der Insulinbedarf reduziert wird

These injections can help prevent conditions like heart disease, vision loss, neurocognitive disorders, peripheral neuropathy, and infertility, among others

Novo Nordisks oral Wegovy, approved in December 2025, was the first oral GLP-1 to hit the obesity market

The constant humidity and unexpected rainfall leave your skin feeling greasy, irritated, and prone to frequent breakouts

Adult patients start with a 17-week binge eating program that includes a weekly virtual small group session led by a therapist and dietitian